This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Malignant neoplasm of other and unspecified urinary organs, including Hilmo
C3_URINARY_TRACT_NAS_WIDE
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
3 out of 7 registries used, show all original rules. |
314 |
4. Check minimum number of eventsNone |
314 |
5. Include endpointsNone |
314 |
6. Filter based on genotype QC (FinnGen only) |
271 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of other and unspecified urinary organs, including Hilmo
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of urinary organs, including Hilmo
- Solid cancers, including Hilmo
- Malignant neoplasm, wide definition
- Malignant neoplasm, including Hilmo
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 271 | 63 | 208 |
| Unadjusted period prevalence (%) | 0.08 | 0.02 | 0.10 |
| Median age at first event (years) | 71.74 | 69.85 | 72.31 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 285
- Matched controls
- 2850
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
153.4
133
*
UKC02
NOMESCO Finland
Cystoscopy
20.0
147.7
205
324
KCD02
NOMESCO Finland
Transurethral resection of bladder
328.4
123.5
117
6
H02AB02
ATC
dexamethasone; systemic
70.3
110.2
61
11
130
Kela drug reimbursment
Malignant tumour
+∞
109.6
98
*
D41.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bladder
72.6
105.5
58
10
R31
ICD-10 Finland
Unspecified haematuria
11.7
96.2
140
218
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
936.8
75.9
71
*
C68.0
ICD-10 Finland
Malignant neoplasm: Urethra
+∞
75.4
69
*
C68.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of urinary organs
+∞
69.7
64
*
A04AA01
ATC
ondansetron; systemic, rectal
32.1
68.7
46
17
C68.9
ICD-10 Finland
Malignant neoplasm: Urinary organ, unspecified
+∞
65.1
60
*
KCD05
NOMESCO Finland
Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)
273.7
65.1
64
*
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
17.1
64.9
58
42
JN4AD
NOMESCO Finland
Body CT examination
11.2
64.7
79
94
A03FA01
ATC
metoclopramide; systemic, rectal
9.0
64.4
100
161
C61
ICD-10 Finland
Malignant neoplasm of prostate
387.9
63.1
61
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
62.9
58
*
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
24.1
60.4
45
22
UKC05
NOMESCO Finland
Cystoscopy and bladder biopsy
241.5
58.4
58
*
KBJ10
NOMESCO Finland
Cutaneous ureteroenterostomy
+∞
57.2
53
*
Z51.5
ICD-10 Finland
Palliative care
10.6
56.1
70
85
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
+∞
55.0
51
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
53.9
50
*
C65
ICD-10 Finland
Malignant neoplasm of renal pelvis
+∞
48.3
45
*
WX302
NOMESCO Finland
Thoracal epidural anesthesy
18.4
47.8
40
25
JN4BD
NOMESCO Finland
Extensive body CT
10.4
45.0
55
64
8120/3-C68.9
ICD-O-3
Transitional cell carcinoma, NOS, of urinary system, NOS
+∞
43.9
41
*
KCD32
NOMESCO Finland
Cystoscopic destruction of tumour of bladder
129.5
42.1
44
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
41.7
39
*
B01AB10
ATC
tinzaparin; parenteral
7.6
39.7
64
104
C66
ICD-10 Finland
Malignant neoplasm of ureter
+∞
39.5
37
*
WX408
NOMESCO Finland
General anesthesy, balanced
5.0
37.8
120
364
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
7.6
37.8
61
99
WF049
NOMESCO Finland
Radiotherapy of metastasis
406.1
36.9
36
*
ZX136
NOMESCO Finland
Intravesicalis
141.1
35.6
37
*
C67.2
ICD-10 Finland
Malignant neoplasm: Lateral wall of bladder
+∞
35.1
33
*
A04AA02
ATC
granisetron; systemic, transdermal
+∞
34.0
32
*
UKB02
NOMESCO Finland
Retrograde ureteroscopy
72.7
34.0
38
6
TKC20
NOMESCO Finland
Catheterisation of bladder
6.1
32.3
65
131
KCC10
NOMESCO Finland
Cystoprostatectomy
+∞
31.9
30
*
PJD54
NOMESCO Finland
Block dissection of iliac lymph nodes
+∞
31.9
30
*
116
Kela drug reimbursment
Prostate cancer
+∞
30.8
29
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
30.8
29
*
KAC20
NOMESCO Finland
Nephroureterectomy
+∞
30.8
29
*
C64
ICD-10 Finland
Malignant neoplasm of kidney, except renal pelvis
+∞
30.8
29
*
XX3DW
NOMESCO Finland
Time consuming IT work
8.9
30.6
41
53
KH1CD
NOMESCO Finland
Very extensive urinary tract ultrasound examination
45.4
29.8
36
9
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
5.1
28.2
71
174
8130/2-C67.9
ICD-O-3
Papillary urothelial carcinoma, non-invasive of bladder, NOS
+∞
26.5
25
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
26.5
25
*
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
24.8
26.4
37
17
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
4.3
26.2
89
275
U06
ICPC
Haematuria
10.4
25.7
30
32
J01MA02
ATC
ciprofloxacin; systemic
3.6
25.1
166
796
KH1BT
NOMESCO Finland
Urinary tract cathetrisation with X-ray guidance
61.8
24.5
28
5
KA1AE
NOMESCO Finland
Kidney ultrasound examination
10.6
24.5
28
29
8312/3-C64.9
ICD-O-3
Renal cell carcinoma, NOS, of kidney, NOS
+∞
24.3
23
*
J01EA01
ATC
trimethoprim; systemic
3.8
24.1
103
372
WF002
NOMESCO Finland
Radical radiotherapy
261.0
24.0
24
*
ZXE30
NOMESCO Finland
More than five and less than seven hours
8.7
23.9
32
41
N02AA05
ATC
oxycodone; systemic
4.0
23.3
86
280
JN4CD
NOMESCO Finland
Very extensive body CT
21.3
23.2
34
18
WZC00
NOMESCO Finland
Treatment plan or consultation
3.6
23.1
108
412
D41.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Renal pelvis
249.2
23.0
23
*
JN3AD
NOMESCO Finland
Abdominal CT examination
4.6
22.3
61
158
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
21.1
20
*
WC305
NOMESCO Finland
Simple therapy of local tumor recidive with biomodifiers
+∞
21.1
20
*
8120/3-C68.0
ICD-O-3
Transitional cell carcinoma, NOS, of urethra
+∞
21.1
20
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
225.8
20.9
21
*
J01MA12
ATC
levofloxacin; systemic
3.5
20.3
90
328
8310/3-C64.9
ICD-O-3
Clear cell adenocarcinoma, NOS, of kidney, NOS
+∞
20.0
19
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
+∞
20.0
19
*
KCC20
NOMESCO Finland
Cystoprostatourethrectomy
+∞
20.0
19
*
D41.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Urethra
+∞
20.0
19
*
U76
ICPC
Malignant neoplasm of bladder
+∞
20.0
19
*
WX402
NOMESCO Finland
General anaesthesia
3.8
19.7
74
241
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
17.5
19.3
30
19
D41.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Ureter
+∞
19.0
18
*
C67.0
ICD-10 Finland
Malignant neoplasm: Trigone of bladder
+∞
19.0
18
*
TJF80
NOMESCO Finland
Ostomy education
107.2
18.8
20
*
XKD00
NOMESCO Finland
Uroflowmetry
3.3
18.8
95
374
WZC30
NOMESCO Finland
Teaching
4.1
18.6
60
175
TPH07
NOMESCO Finland
Cathetrisation of artery
4.0
18.2
61
183
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
3.4
18.2
83
306
L02AE02
ATC
leuprorelin; implant, parenteral
+∞
17.9
17
*
UKA02
NOMESCO Finland
Retrograde ureteronephroscopy
191.4
17.7
18
*
A04AD12
ATC
aprepitant; systemic
+∞
16.8
16
*
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
7.3
16.4
25
37
WX320
NOMESCO Finland
Spinalanesthesy
3.0
16.4
103
455
KCC30
NOMESCO Finland
Cystectomy with excision of female internal genital organs
+∞
15.8
15
*
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
+∞
15.8
15
*
8120/3-C68.8
ICD-O-3
Transitional cell carcinoma, NOS, of overlapping lesion of urinary organs
+∞
15.8
15
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
15.8
15
*
KAC21
NOMESCO Finland
Percutaneous endoscopic nephroureterectomy
+∞
15.8
15
*
R82.8
ICD-10 Finland
Abnormal findings on cytological and histological examination of urine
+∞
15.8
15
*
TPH04
NOMESCO Finland
Cathetrisation of vein
3.0
15.3
89
375
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
14.7
14
*
KAC10
NOMESCO Finland
Total nephrectomy with capsule
+∞
14.7
14
*
308
Kela drug reimbursment
Alprostadil, sildenafil and combination product containing aviptadil and phentolamine
+∞
14.7
14
*
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
+∞
14.7
14
*
JN3BD
NOMESCO Finland
Extensive abdominal CT
4.2
14.7
43
116
N30.0
ICD-10 Finland
Acute cystitis
3.5
14.7
58
193
KH1AD
NOMESCO Finland
CT of urinary organs
5.9
13.8
26
48
KH1BD
NOMESCO Finland
Extensive urinary tract CT examination
36.0
13.7
17
5
WC105
NOMESCO Finland
Simple cytostatic therapy of local tumor recidive
+∞
13.6
13
*
L03AA02
ATC
filgrastim; parenteral
+∞
13.6
13
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
13.6
13
*
L01BC06
ATC
capecitabine; oral
+∞
13.6
13
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
13.6
13
*
B02AA02
ATC
tranexamic acid; systemic
4.1
13.5
40
109
WX404
NOMESCO Finland
Intravenous generell anesthesy
3.2
13.3
62
228
KC1GB
NOMESCO Finland
Cystography with X-ray
73.2
12.7
14
*
KCB00
NOMESCO Finland
Biopsy of bladder
73.2
12.7
14
*
KBV12
NOMESCO Finland
Transluminal endoscopic removal of stent from ureter
14.1
12.6
21
16
JEA00
NOMESCO Finland
Appendectomy
6.0
12.6
23
41
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
12.6
12
*
KDD32
NOMESCO Finland
Urethroscopic destruction of tumour of urethra
+∞
12.6
12
*
B01AB05
ATC
enoxaparin; parenteral
2.6
12.4
104
521
R33
ICD-10 Finland
Retention of urine
3.1
12.4
61
231
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
48.8
12.0
14
*
KCW02
NOMESCO Finland
Lavation of bladder for coagulated blood
14.4
11.6
19
14
8000/3-C68.9
ICD-O-3
Neoplasm, malignant of urinary system, NOS
+∞
11.5
11
*
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
+∞
11.5
11
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
11.5
11
*
L02BB03
ATC
bicalutamide; oral
+∞
11.5
11
*
J01CA08
ATC
pivmecillinam; oral
2.6
11.4
88
421
JN2CG
NOMESCO Finland
Extensive MRI examination of lower part of abdoment with high intensity magnet
36.7
11.4
14
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.3
11.1
163
1035
ZXE10
NOMESCO Finland
More than one and less than three hours
2.4
11.1
114
621
Z3231
NOMESCO Finland
Registered nurse
2.5
10.9
92
458
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
4.3
10.8
29
73
Y77
ICPC
Malignant neoplasm prostate
114.0
10.5
11
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
114.0
10.5
11
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
10.5
10
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
10.5
10
*
KH1YT
NOMESCO Finland
Percutaneous implantation of endoprothesis with radiological guidance
+∞
10.5
10
*
KBD00
NOMESCO Finland
Partial excision of ureter
+∞
10.5
10
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
10.5
10
*
KDC00
NOMESCO Finland
Urethrectomy
+∞
10.5
10
*
ZXD10
NOMESCO Finland
Scheduled procedure
2.3
10.0
120
693
U07
ICPC
Urine symptom/complaint other
3.4
9.9
38
123
TKW99
NOMESCO Finland
Other minor surgical procedure in urology
20.9
9.9
14
7
N17.9
ICD-10 Finland
Acute renal failure, unspecified
4.0
9.9
29
78
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.6
9.6
63
277
7125
FHL
Nephrectomy (extrrafascial)
103.3
9.5
10
*
PJD44
NOMESCO Finland
Excision of iliac lymph nodes
103.3
9.5
10
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
9.4
9
*
C67
ICD-10 Finland
Malignant neoplasm of bladder
+∞
9.4
9
*
A79
ICPC
Malignancy NOS
+∞
9.4
9
*
1899X
ICD-9 Finland
Malignant neoplasm of kidney and other and unspecified urinary organs, Urinary organ, site unspecified[NEOPLASMA MAL ORG URIN NUD,EI HIST VAHV]
+∞
9.4
9
*
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
8.2
9.3
20
26
SPAT1125
SPAT
Stoma care and guidance
10.6
9.2
17
17
N30.9
ICD-10 Finland
Cystitis, unspecified
3.9
9.1
28
78
WW500
NOMESCO Finland
Blood transfusion
8.4
9.0
19
24
UKD02
NOMESCO Finland
Urethroscopy
24.9
9.0
12
5
KED22
NOMESCO Finland
Transurethral resection of prostate
3.0
9.0
44
165
U99
ICPC
Urinary disease other
14.6
8.8
14
10
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
8.7
8.7
18
22
JFB00
NOMESCO Finland
Partial resection of small intestine
20.8
8.5
12
6
ZX120
NOMESCO Finland
Intravenous
3.5
8.5
31
97
U08
ICPC
Urinary retention
4.9
8.5
19
41
ZXE20
NOMESCO Finland
More than three and less than five hours
2.7
8.4
51
214
D09.0
ICD-10 Finland
Carcinoma in situ: Bladder
+∞
8.4
8
*
YJ2VG
NOMESCO Finland
MRI examination of pelvis with high intensity magnet for dose design of radiotherapy
+∞
8.4
8
*
U77
ICPC
Malignant neopl urinary tract other
+∞
8.4
8
*
8070/3-C68.0
ICD-O-3
Squamous cell carcinoma, NOS, of urethra
+∞
8.4
8
*
8120/3-C65.9
ICD-O-3
Transitional cell carcinoma, NOS, of renal pelvis
+∞
8.4
8
*
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
+∞
8.4
8
*
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
+∞
8.4
8
*
KH1FT
NOMESCO Finland
Exchange of urinary catheter with radiological guidance
+∞
8.4
8
*
C67.4
ICD-10 Finland
Malignant neoplasm: Posterior wall of bladder
+∞
8.4
8
*
C67.1
ICD-10 Finland
Malignant neoplasm: Dome of bladder
+∞
8.4
8
*
KEC00
NOMESCO Finland
Retropubic radical prostatectomy
+∞
8.4
8
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
8.4
8
*
ZXA05
NOMESCO Finland
Left side
2.2
8.3
87
469
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
6.6
8.2
20
32
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
4.3
7.9
21
52
R4110
NOMESCO Finland
Physiotherapy
2.2
7.9
85
461
KDV12
NOMESCO Finland
Urethroscopic internal urethrotomy
15.6
7.8
12
8
TKD00
NOMESCO Finland
Dilatation of urethra
25.8
7.6
10
*
KBV15
NOMESCO Finland
Cystoscopic change of ureteral stent
25.8
7.6
10
*
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
4.1
7.6
21
54
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
82.1
7.5
8
*
8120/2-C67.9
ICD-O-3
Urothelial carcinoma in situ of bladder, NOS
82.1
7.5
8
*
U05
ICPC
Urination problems other
3.3
7.4
29
95
C67.6
ICD-10 Finland
Malignant neoplasm: Ureteric orifice
+∞
7.3
7
*
KDD96
NOMESCO Finland
Other partial excision of urethra
+∞
7.3
7
*
1890B
ICD-9 Finland
Malignant neoplasm of kidney and other and unspecified urinary organs, Kidney, except pelvis[NEOPL MAL RENIS PELVI EXCEPTO,ADENOCARCINOMA]
+∞
7.3
7
*
KDD30
NOMESCO Finland
Destruction of tumour of urethra
+∞
7.3
7
*
KA3EB
NOMESCO Finland
Antegrade pyelography
+∞
7.3
7
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
+∞
7.3
7
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
7.3
7
*
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
7.3
7
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
7.3
7
*
WX702
NOMESCO Finland
Supraglottic ventilation device
4.3
7.2
19
47
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
3.0
7.2
34
125
ZXE00
NOMESCO Finland
One hour or less
2.0
7.1
109
672
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
4.4
7.1
18
43
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.5
7.0
48
213
Z2446
NOMESCO Finland
Social worker
3.6
6.9
23
68
TKC50
NOMESCO Finland
Training of urinary bladder
41.1
6.8
8
*
KA1FN
NOMESCO Finland
Isotope renography
23.1
6.7
9
*
KCW96
NOMESCO Finland
Other operations on bladder
23.1
6.7
9
*
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
23.1
6.7
9
*
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
4.3
6.6
17
41
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.6
6.6
40
167
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
3.6
6.6
22
65
TKE00
NOMESCO Finland
Needle biopsy of prostate
4.1
6.5
18
46
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
4.2
6.4
17
42
ZXD05
NOMESCO Finland
Urgent procedure
2.0
6.4
91
543
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.4
6.3
47
217
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
6.3
6
*
UKC12
NOMESCO Finland
Retrograde endoscopy of cutaneous cystoenterostomy
+∞
6.3
6
*
KBJ60
NOMESCO Finland
Anastomosis of ureter to urethra with interposition of ileum
+∞
6.3
6
*
KA3GB
NOMESCO Finland
Retrograde pyelography
+∞
6.3
6
*
UKB12
NOMESCO Finland
Retrograde endoscopy of cutaneous ureteroenterostomy
+∞
6.3
6
*
D41.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Urinary organ, unspecified
+∞
6.3
6
*
115
Kela drug reimbursment
Breast cancer
+∞
6.3
6
*
1888X
ICD-9 Finland
Malignant neoplasm of bladder, Other specified sites of bladder
+∞
6.3
6
*
C64.80
ICD-10 Finland
Wilms tumour
+∞
6.3
6
*
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
+∞
6.3
6
*
KDW96
NOMESCO Finland
Other operations on urethra
+∞
6.3
6
*
180
Kela drug reimbursment
Interferon alfa
+∞
6.3
6
*
159
Kela drug reimbursment
Pazopanib
+∞
6.3
6
*
8120/3-C66.9
ICD-O-3
Transitional cell carcinoma, NOS, of ureter
+∞
6.3
6
*
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
3.1
6.2
26
89
R93.4
ICD-10 Finland
Abnormal findings on diagnostic imaging of urinary organs
12.9
6.1
10
8
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
2.6
6.1
38
161
ZXE40
NOMESCO Finland
More than seven and less than nine hours
8.9
6.1
12
14
R50.9
ICD-10 Finland
Fever, unspecified
2.3
6.1
47
221
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
104
360
3.97
26.12
10.8
6.4
105.39
104.54
mmol/l
1.03
104
360
158
772
3.35
22.48
9.7
3.3
179.02
156.23
e6/l
0.08
131
590
177
927
3.40
22.39
4.0
2.5
—
—
estimate
—
0
0
143
667
3.30
21.83
9.9
3.2
0.42
0.39
e6/l
0.11
122
489
49
114
4.98
20.37
3.4
1.4
9.25
2.75
ug/l
1.46
36
82
97
372
3.44
20.19
6.6
2.7
0.80
0.83
mmol/l
2.16
88
341
123
547
3.20
19.99
5.3
2.6
4.69
4.44
e6/l
0.08
117
493
89
327
3.50
19.78
7.6
5.3
1.04
1.03
mmol/l
0.17
84
300
114
495
3.17
19.16
3.3
2.1
—
—
—
0
0
159
853
2.95
18.00
10.9
4.0
308.58
104.41
e6/l
0.71
133
607
94
378
3.22
17.82
10.1
3.1
1.21
1.69
e6/l
0.36
62
189
95
411
2.97
15.58
10.0
2.9
2.29
1.04
e6/l
0.73
63
221
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
35
78
4.98
15.17
3.5
2.3
0.35
0.44
iu/ml
0.40
20
41
181
1110
2.73
14.80
15.0
5.3
4.93
4.51
e9/l
1.04
152
943
65
234
3.30
14.53
10.0
6.8
13.50
11.91
mmol/l
0.61
60
222
164
994
2.53
13.18
9.1
3.7
32.58
35.07
g/l
5.54
155
920
70
286
2.92
12.45
6.1
3.4
1.22
1.67
mmol/l
0.45
60
243
163
1036
2.34
11.10
11.7
6.0
1.20
1.20
mmol/l
0.06
153
924
49
174
3.19
11.05
2.1
1.9
0.21
0.20
g/l
0.30
39
150
178
1199
2.29
10.24
17.7
18.7
1.30
1.39
inr
1.12
147
1004
217
1592
2.52
10.23
13.9
5.4
89.98
79.10
u/l
1.02
210
1463
170
1150
2.19
9.33
12.3
6.4
1.20
1.20
mmol/l
0.10
150
969
15
12
13.11
8.97
1.2
1.1
24.91
23.61
ng/l
0.10
15
12
124
753
2.14
8.86
7.6
2.1
2.37
2.35
mmol/l
0.54
116
635
71
345
2.41
8.66
9.3
6.6
-1.03
1.16
mmol/l
4.99
60
280
43
169
2.82
8.04
1.8
1.6
—
—
—
0
0
160
1105
2.02
7.76
6.1
4.1
0.00
0.00
estimate
-0.00
40
233
161
1127
1.99
7.38
6.1
4.1
28.30
0.00
estimate
0.49
44
241
160
1133
1.94
6.92
6.1
4.1
0.00
0.02
estimate
0.50
43
225
34
131
2.81
6.58
1.6
1.5
—
—
—
0
0
77
443
2.01
5.98
2.1
1.9
—
—
—
0
0
39
171
2.48
5.85
5.8
3.9
0.41
2.27
mmol/l
2.60
30
118
43
205
2.29
5.36
3.8
2.4
0.53
0.51
e6/l
0.04
43
193
16
44
3.79
5.28
2.1
2.3
89.87
82.57
%
0.65
16
44
68
391
1.97
5.23
3.3
2.6
2.13
2.20
g/l
0.48
62
362
72
429
1.91
4.97
3.4
2.6
10.34
12.81
umol/l
2.61
66
397
64
369
1.95
4.86
3.3
2.6
19.47
23.12
%
1.50
59
344
46
236
2.13
4.79
4.2
3.0
4.83
4.56
kpa
0.36
46
226
35
161
2.34
4.73
1.8
1.6
—
—
—
0
0
25
98
2.70
4.69
6.7
4.8
23.58
24.88
mmol/l
1.32
25
90
13
27
4.99
4.55
2.8
1.5
36.80
48.61
u/ml
0.13
13
27
59
338
1.94
4.55
2.0
1.9
—
—
—
0
0
30
131
2.44
4.54
1.5
1.6
1.98
1.59
g/l
1.14
24
118
40
200
2.16
4.44
6.3
3.8
4.88
5.13
kpa
1.26
40
193
25
106
2.49
4.03
2.2
1.6
15.24
3.78
ug/l
0.40
20
88
93
636
1.69
3.94
4.4
2.5
28.66
42.10
u/l
1.89
87
595
54
317
1.87
3.84
2.1
1.9
—
—
—
0
0
16
55
3.02
3.80
1.3
1.3
—
—
—
0
0
16
55
3.02
3.80
1.3
1.3
—
—
—
0
0
96
669
1.66
3.76
2.6
2.3
2.99
2.76
mg/l
0.47
75
560
20
80
2.61
3.63
1.4
1.3
—
—
—
0
0
15
52
2.99
3.52
1.3
1.3
—
—
—
0
0
75
502
1.67
3.39
6.0
2.1
2.52
2.44
mmol/l
2.19
68
430
90
636
1.61
3.27
6.3
4.1
0.00
0.00
estimate
-0.00
30
212
14
51
2.84
3.03
1.7
1.6
—
—
—
0
0
36
200
1.92
3.03
2.2
1.7
65.97
66.34
g/l
0.11
30
179
229
2027
1.66
2.92
37.6
16.4
42.12
27.45
mg/l
7.01
219
1665
6
9
6.78
2.88
1.3
1.1
3.10
5.74
nmol/l
—
6
9
83
597
1.55
2.74
4.0
2.6
402.07
375.58
umol/l
1.28
70
507
9
24
3.84
2.69
2.1
2.5
—
—
—
0
0
5
7
7.24
2.56
1.2
1.6
—
—
—
0
0
5
7
7.24
2.56
1.2
1.6
—
—
—
0
0
19
94
2.09
2.21
2.7
3.7
—
—
—
0
0
8
24
3.40
2.19
1.0
1.2
—
—
—
0
0
117
937
1.42
2.19
3.7
3.0
221.01
144.20
ug/l
1.06
107
857
6
14
4.35
2.16
1.2
1.1
—
—
—
0
0
24
132
1.89
2.11
6.4
3.2
1.02
1.02
ratio
1.37
24
123
5
10
5.07
2.08
1.2
1.1
—
—
—
0
0
26
150
1.81
1.99
4.4
2.6
0.56
0.62
%
0.45
26
150
6
16
3.81
1.94
1.5
1.3
—
—
—
0
0
6
17
3.58
1.84
1.5
1.3
—
—
—
0
0
6
17
3.58
1.84
1.5
1.3
—
—
—
0
0
116
950
1.37
1.83
2.1
2.3
—
—
—
0
0
124
1030
1.36
1.78
5.2
4.4
45.40
48.91
ng/l
0.11
112
814
6
18
3.38
1.75
1.5
1.3
—
—
—
0
0
6
18
3.38
1.75
1.5
1.3
—
—
—
0
0
6
18
3.38
1.75
1.5
1.3
—
—
—
0
0
12
55
2.23
1.70
1.8
1.4
—
—
—
0
0
36
239
1.58
1.68
5.5
3.3
—
—
—
0
0
61
456
1.43
1.62
1.7
1.7
2.85
1.49
mg/l
1.03
56
361
69
528
1.40
1.61
6.2
4.3
60.23
426.78
ng/l
2.94
63
460
14
71
2.02
1.56
2.1
1.2
1.75
1.58
ratio
—
9
41
67
513
1.40
1.56
1.8
1.8
944.26
1175.58
nmol/l
1.29
50
403
229
2119
1.41
1.51
17.6
10.5
23.62
25.40
u/l
1.01
222
2021
102
842
1.33
1.47
7.0
4.2
0.00
0.00
estimate
-0.00
26
191
17
96
1.82
1.42
1.9
1.6
—
—
—
0
0
5
17
2.97
1.36
1.0
1.2
7.90
220.05
u/ml
—
5
17
231
2155
1.38
1.32
46.2
21.2
138.77
139.74
mmol/l
5.57
226
2099
231
2157
1.37
1.30
46.6
21.3
4.09
4.03
mmol/l
2.01
225
2098
8
35
2.32
1.28
1.9
4.2
5.20
13.24
pmol/l
—
8
35
233
2187
1.36
1.19
53.8
24.4
91.57
91.82
fl
0.32
228
2144
233
2188
1.36
1.18
53.9
24.5
4.18
4.45
e12/l
11.05
222
2111
233
2188
1.36
1.18
53.9
24.5
245.09
232.79
e9/l
1.85
225
2125
210
1944
1.30
1.18
39.5
16.1
62.07
71.99
ml/min/173m2
7.69
200
1800
15
88
1.74
1.13
2.0
1.4
—
—
—
0
0
143
1270
1.25
1.10
5.8
4.5
4.47
2.15
ug/l
0.86
120
1118
84
702
1.28
1.07
2.9
3.0
0.95
0.81
ug/l
0.17
63
485
71
581
1.30
1.07
5.6
3.6
0.00
0.00
estimate
-0.00
24
178
69
830
0.78
1.03
2.0
2.0
1.27
1.29
mmol/l
0.09
57
670
23
157
1.51
0.99
5.4
3.9
46.07
48.38
%
0.16
23
152
8
42
1.93
0.89
1.4
1.5
—
—
—
0
0
10
56
1.81
0.89
2.4
1.4
—
—
—
0
0
30
397
0.73
0.88
1.3
1.3
1.10
1.73
u/ml
—
6
111
25
181
1.42
0.83
2.8
2.2
43.00
56.32
ml/min/173m2
1.61
15
75
171
1585
1.20
0.76
4.6
4.4
21.70
13.53
mm/h
4.88
160
1440
161
1489
1.19
0.72
5.5
3.8
15.15
15.05
pmol/l
0.19
140
1313
24
317
0.73
0.71
1.1
1.3
21.27
12.59
u/ml
—
6
106
128
1162
1.18
0.71
2.5
2.3
92.17
93.68
pmol/l
0.15
93
615
5
28
1.80
0.66
1.2
1.1
—
—
—
0
0
5
30
1.68
0.61
4.2
4.6
—
—
—
0
0
27
210
1.32
0.61
10.3
5.4
23.20
24.40
mmol/l
0.91
27
203
179
1893
0.85
0.61
4.4
4.8
1.36
1.26
mmol/l
1.29
156
1688
27
341
0.77
0.60
1.1
1.3
24.67
40.33
iu/ml
—
9
107
0
22
0.00
0.59
0.0
1.0
—
558.88
—
0
16
0
22
0.00
0.59
0.0
1.0
—
41.79
—
0
17
6
36
1.68
0.57
1.2
1.2
48.23
22.61
u/l
—
6
31
13
90
1.47
0.56
1.1
1.2
0.05
0.31
g/l
—
8
78
188
1971
0.86
0.53
4.9
5.6
1.33
1.39
mmol/l
1.03
167
1774
102
932
1.15
0.49
3.6
3.4
2764.27
1808.50
ng/l
0.51
97
812
7
50
1.41
0.45
2.9
1.5
—
—
—
0
0
10
69
1.47
0.45
1.1
1.2
—
—
—
0
0
101
930
1.13
0.43
3.8
4.4
14.29
8.43
mg/mmol
0.91
81
608
191
1987
0.88
0.42
5.0
5.7
4.28
4.27
mmol/l
0.04
170
1809
0
16
0.00
0.41
0.0
1.5
—
—
—
0
0
15
192
0.77
0.39
1.3
1.3
—
—
—
0
0
85
782
1.12
0.37
1.8
1.8
18.52
20.13
nmol/l
0.44
70
647
58
523
1.14
0.34
7.0
4.5
1.02
1.02
kg/l
2.43
47
343
198
2042
0.90
0.32
5.8
6.6
2.41
2.44
mmol/l
0.15
177
1848
7
52
1.35
0.31
3.0
1.4
—
—
—
0
0
8
62
1.30
0.28
2.3
1.4
—
—
—
0
0
9
120
0.74
0.28
1.7
1.4
—
—
—
0
0
5
75
0.66
0.26
1.0
1.0
—
—
—
0
0
194
1992
0.92
0.25
8.3
7.7
41.92
40.99
mmol/mol
0.60
173
1830
0
10
0.00
0.21
0.0
2.4
—
720.50
—
0
10
0
12
0.00
0.21
0.0
1.2
—
239.83
—
0
6
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
0
13
0.00
0.21
0.0
1.6
—
—
—
0
0
0
14
0.00
0.20
0.0
1.2
—
148.81
—
0
14
0
14
0.00
0.20
0.0
1.6
—
—
—
0
0
129
1245
1.07
0.19
3.2
3.1
74.36
52.22
u/l
0.80
121
1139
27
295
0.91
0.14
16.9
7.5
—
—
—
0
0
192
1887
1.05
0.13
6.4
4.8
2.01
2.01
mu/l
0.00
171
1671
105
1019
1.05
0.12
4.0
4.2
19.53
24.79
%
3.35
55
530
5
46
1.09
0.09
2.0
1.6
—
692.00
—
0
5
5
48
1.04
0.09
1.8
1.3
—
—
—
0
0
11
124
0.88
0.09
2.2
2.6
—
13.21
—
0
7
54
561
0.95
0.08
2.0
1.9
295349186.56
407.94
pmol/l
0.49
43
455
6
58
1.04
0.08
1.7
1.5
—
0.08
—
0
12
5
64
0.78
0.08
1.0
1.3
—
—
—
0
0
19
176
1.09
0.07
1.9
1.4
—
—
—
0
0
6
75
0.80
0.07
1.2
1.7
—
—
—
0
0
9
105
0.85
0.06
4.4
2.4
688.56
854.91
ug/l
—
9
97
91
928
0.97
0.06
2.4
2.4
76.60
77.48
nmol/l
0.10
84
797
201
2018
0.99
0.01
6.1
5.7
6.32
6.20
mmol/l
0.53
176
1792
11
104
1.06
0.01
1.1
1.4
—
26.98
—
0
8
29
294
0.98
0.00
4.0
5.4
32.45
31.90
%
0.09
20
181
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
0.00
0.0
2.3
—
—
—
0
0
6
69
0.87
0.00
1.2
1.5
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
1.05
—
0
6
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.1
—
36.69
—
0
9
5
54
0.92
-0.00
3.6
1.3
—
—
—
0
0
5
53
0.94
-0.00
1.0
1.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.7
—
39.54
—
0
7
0
7
0.00
-0.00
0.0
2.6
—
13.39
—
0
7
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
2584.71
—
0
7
5
53
0.94
-0.00
1.0
1.2
—
—
—
0
0
0
9
0.00
-0.00
0.0
2.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
32.30
—
0
5
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
2.1
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: C3_URINARY_TRACT_NAS_WIDE – Malignant neoplasm of other and unspecified urinary organs, including Hilmo
GWS hits: -
This endpoint is excluded (different definition than used in FinnGen).